ClinConnect ClinConnect Logo
Search / Trial NCT03667599

A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Launched by DUKE UNIVERSITY · Sep 10, 2018

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the well-being of caregivers who look after patients receiving a specific type of treatment called autologous hematopoietic stem cell transplantation, which is often used for cancer or certain non-cancer illnesses. The study will compare how caregivers feel and manage their responsibilities when patients receive care at home versus standard care in a medical facility. Caregivers play a vital role in supporting patients, and understanding their experiences can help improve care for both patients and their caregivers.

To qualify for the study, patients must be between 18 and 80 years old, scheduled for this type of transplant, and able to communicate in English. They also need to have a suitable home environment for recovery. Caregivers must be identified by the patient and should be able to provide necessary support, like driving and helping with daily tasks. There are no specific exclusions for caregivers. Participants can expect to share their experiences, which will help researchers understand how home care impacts the well-being of those caring for patients during recovery.

Gender

ALL

Eligibility criteria

  • Patient Inclusion Criteria:
  • Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness
  • Age 18-80 years
  • Karnofsky Performance Scale KPS\> 80
  • Able to read/write English
  • A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke
  • Patient Exclusion Criteria:
  • Lack of a caregiver
  • Pregnant women
  • Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
  • Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota
  • Caregiver Inclusion Criteria:
  • Identified by patient as their primary caregiver
  • Meet standard clinical criteria for being a caregiver (able to drive and take care of patient)
  • Age 18-80 years
  • Caregiver Exclusion Criteria:
  • None

About Duke University

Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.

Locations

Durham, North Carolina, United States

Durham, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Anthony Sung, MD

Principal Investigator

Duke Health

Nelson Chao, MD

Principal Investigator

Duke Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials